Avenda Health
Avenda Health Receives FDA Investigational Device Exemption (IDE) for its AI-Enabled prostate cancer therapy, FocalPoint ablation system
Source: hitconsultant.net
Stay updated with breaking news from Enabled Prostate Cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avenda Health Receives FDA Investigational Device Exemption (IDE) for its AI-Enabled prostate cancer therapy, FocalPoint ablation system